Repo Dosen ULM

Stevia rebaudiana as a nutraceutical for COVID-19 patients with no sugar diet during recovery and its nanoparticle application

Show simple item record

dc.contributor.author RIZKI, MUHAMMAD IKHWAN
dc.date.accessioned 2022-06-09T01:22:56Z
dc.date.available 2022-06-09T01:22:56Z
dc.date.issued 2022
dc.identifier.issn 1477-2701
dc.identifier.uri https://repo-dosen.ulm.ac.id//handle/123456789/24452
dc.description.abstract Abstract Introduction: Some patients with comorbidity such as diabetes are at risk of worsening after being infected with the COVID-19 and they usually adjust their diet during the recovery process. Aim: To explore the use of Stevia rebaudiana leaves as a natural sweetener recommended for COVID-19 patients and the nanoparticle approach of S. rebaudiana extract to improve the efficacy. Methods: Four electronic databases (Google Scholar, PubMed, Scopus, and ScienceDirect) were used with specified inclusion and exclusion criteria set. Results: The glycosides produced by S. rebaudiana are 300 times sweeter than sucrose, low in calories, and can control blood sugar levels and increase insulin secretion. The application of nanoparticles in S. rebaudiana extract is a new step to maximise efficacy, increase stability and solubility. Conclusion: S. rebaudiana can be used as an alternative diet for COVID-19 diabetes patients. The application of the nanoparticles can increase the stability and solubility, thus improving the efficacy. en_US
dc.publisher Universitas Lambung Mangkurat en_US
dc.subject Research Subject Categories::PHARMACY en_US
dc.title Stevia rebaudiana as a nutraceutical for COVID-19 patients with no sugar diet during recovery and its nanoparticle application en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account